BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shimony A, Fox BD, Afilalo J, Rudski LG, Hirsch A, Langleben D. Pulmonary arterial hypertension in the elderly-clinical characteristics and long-term survival. Lung 2012;190:645-9. [PMID: 23064491 DOI: 10.1007/s00408-012-9425-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Emmons‐bell S, Johnson C, Boon‐dooley A, Corris PA, Leary PJ, Rich S, Yacoub M, Roth GA. Prevalence, incidence, and survival of pulmonary arterial hypertension: A systematic review for the global burden of disease 2020 study. Pulm circ 2022;12. [DOI: 10.1002/pul2.12020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Ginoux M, Turquier S, Chebib N, Glerant JC, Traclet J, Philit F, Sénéchal A, Mornex JF, Cottin V. Impact of comorbidities and delay in diagnosis in elderly patients with pulmonary hypertension. ERJ Open Res 2018;4:00100-2018. [PMID: 30510957 DOI: 10.1183/23120541.00100-2018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
3 Chebib N, Mornex JF, Traclet J, Philit F, Khouatra C, Zeghmar S, Turquier S, Cottin V. Pulmonary hypertension in chronic lung diseases: comparison to other pulmonary hypertension groups. Pulm Circ 2018;8:2045894018775056. [PMID: 29671674 DOI: 10.1177/2045894018775056] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
4 Hjalmarsson C, Rådegran G, Kylhammar D, Rundqvist B, Multing J, Nisell MD, Kjellström B; SveFPH and SPAHR. Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension. Eur Respir J 2018;51:1702310. [PMID: 29622568 DOI: 10.1183/13993003.02310-2017] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
5 Reque J, Quiroga B, Ruiz C, Villaverde MT, Vega A, Abad S, Panizo N, López-gómez JM. Pulmonary hypertension is an independent predictor of cardiovascular events and mortality in haemodialysis patients: Pulmonary hypertension is an independent predictor of cardiovascular events and mortality in hemodialysis patients. Nephrology 2016;21:321-6. [DOI: 10.1111/nep.12595] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
6 Rothbard N, Agrawal A, Fischer C, Talwar A, Sahni S. Pulmonary arterial hypertension in the elderly: Clinical perspectives. Cardiol J 2020;27:184-93. [PMID: 30155860 DOI: 10.5603/CJ.a2018.0096] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 DesJardin JT, Kolaitis NA, Kime N, Kronmal RA, Benza RL, Elwing JM, Lammi MR, McConnell JW, Presberg KW, Sager JS, Shlobin OA, De Marco T; PHAR Investigators. Age-related differences in hemodynamics and functional status in pulmonary arterial hypertension: Baseline results from the Pulmonary Hypertension Association Registry. J Heart Lung Transplant 2020;39:945-53. [PMID: 32507341 DOI: 10.1016/j.healun.2020.05.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
8 Baggen VJM, Driessen MMP, Post MC, van Dijk AP, Roos-Hesselink JW, van den Bosch AE, Takkenberg JJM, Sieswerda GT. Echocardiographic findings associated with mortality ortransplant in patients with pulmonary arterial hypertension:A systematic review and meta-analysis. Neth Heart J 2016;24:374-89. [PMID: 27189216 DOI: 10.1007/s12471-016-0845-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 George MG, Schieb LJ, Ayala C, Talwalkar A, Levant S. Pulmonary hypertension surveillance: United States, 2001 to 2010. Chest 2014;146:476-95. [PMID: 24700091 DOI: 10.1378/chest.14-0527] [Cited by in Crossref: 79] [Cited by in F6Publishing: 68] [Article Influence: 9.9] [Reference Citation Analysis]
10 Sitbon O, Howard L. Management of pulmonary arterial hypertension in patients aged over 65 years. Eur Heart J Suppl 2019;21:K29-36. [PMID: 31857798 DOI: 10.1093/eurheartj/suz206] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Pugh ME, Sivarajan L, Wang L, Robbins IM, Newman JH, Hemnes AR. Causes of pulmonary hypertension in the elderly. Chest 2014;146:159-66. [PMID: 24480915 DOI: 10.1378/chest.13-1900] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
12 Chebib N, Cottin V, Taharo-Ag-Ralissoum M, Chuzeville M, Mornex JF. Epoprostenol discontinuation in patients with pulmonary arterial hypertension: a complex medical and social problem. Pulm Circ 2018;8:2045893217753352. [PMID: 29283031 DOI: 10.1177/2045893217753352] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
13 Culley MK, Chan SY. Endothelial Senescence: A New Age in Pulmonary Hypertension. Circ Res 2022;130:928-41. [PMID: 35298304 DOI: 10.1161/CIRCRESAHA.121.319815] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Zhan Y, Burstein B, Abualsaud AO, Nosair M, Hirsch AM, Lesenko L, Langleben D. Right ventricular ST-elevation myocardial infarction as a cause of death in idiopathic pulmonary arterial hypertension. Pulm Circ 2017;7:555-8. [PMID: 28597772 DOI: 10.1177/2045893217704435] [Reference Citation Analysis]